Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carisolv
- Development stage
- Unknown
- Lead developer
- RLS Global
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Carisolv is a chemomechanical caries removal system used as a minimally invasive alternative to traditional rotary drilling for the treatment of dental caries. Developed by RLS Global AB, the system consists of a topical gel formed by mixing two solutions. The active component is sodium hypochlorite, which is buffered by three amino acids (glutamic acid, leucine, and lysine) to selectively dissolve demineralized carious dentine while leaving healthy dental tissue and pulp intact. It is particularly utilized in pediatric dentistry and is used in conjunction with specialized hand instruments for the gentle excavation of softened tissue.
- Brand names
- Carisolv
02
Targets
COL1 (Collagen type I)
Beyond the preview
Go deeper on Carisolv.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Carisolv.